Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to Verona Pharma's First Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
Verona Pharma Plc (VRNA)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
11 Best Undervalued UK Stocks To Buy Now
In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q3 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma's Third Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
12 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q2 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma Second Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time all participants are in listen-only mode.
Verona Pharma plc (NASDAQ:VRNA) Q1 2023 Earnings Call Transcript
Operator: Good morning. Welcome to Verona Pharma's First Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a mode.
Verona Pharma plc (NASDAQ:VRNA) Q4 2022 Earnings Call Transcript
Operator: Welcome to Verona Pharma's, Fourth Quarter and Full Year 2022 Financial Results and Operating Highlights Conference Call. At this time all participants are in a listen-only mode.
12 Best Performing NASDAQ Stocks in 2022
The S&P 500 rose 0.6% to 3,844.82 on December 23, while the Nasdaq Composite gained 0.2% to close at 10,497.86. The Dow Jones Industrial Average also closed 176.44 points or 0.5% higher at 33,203.93.
5 Best Performing Biotech Stocks in 2022
Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory diseases with unmet...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
